Financials
Income statement
Fiscal date | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total reported revenue | 18.6B | 19.7B | 19.5B | 12.6B |
Cost of revenue | 14.9B | 15.6B | 16.1B | 10.3B |
Gross profit | 3.7B | 4.1B | 3.4B | 2.4B |
Operating expense | ||||
Research & development | 721.9M | 876.7M | 939.1M | 603.3M |
Selling general and admin | 285.5M | 319.4M | 301.0M | 222.9M |
Other operating expenses | 96.3M | 107.9M | 66.7M | 55.9M |
Operating income | 2.2B | 2.5B | 1.8B | 1.2B |
Non operating interest income | ||||
Income | 197.1M | 214.0M | 141.7M | 144.7M |
Expense | 49.1M | 60.5M | 53.3M | 44.6M |
Other income expense | — | — | — | — |
Pretax income | 2.1B | 2.1B | 1.7B | 1.2B |
Tax provision | 295.5M | 249.9M | -8.7M | 107.1M |
Net income | 1.8B | 1.8B | 1.7B | 1.1B |
Basic EPS | 1.1 | 1.1 | 1.0 | 0.7 |
Diluted EPS | 1.1 | 1.1 | 1.0 | 0.7 |
Basic average shares | 1.6B | 1.6B | 1.6B | 1.6B |
Diluted average shares | 1.6B | 1.6B | 1.6B | 1.6B |
EBITDA | 3.1B | 3.2B | 2.3B | 1.7B |
Net income from continuing op. | 1.8B | 1.8B | 1.7B | 1.1B |
Minority interests | -1.4M | -9.8M | 1.2M | 746.1K |
Preferred stock dividends | 0 | 0 | 0 | 0 |